TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Capital Structure Changes 8-K Filing 2025 - Equity Offerings On May 20, 2025, Teva Pharmaceutical Industries announced a €1 billion and $1.2 billion offering of Senior Notes due between 2030 and 2032, with the sale expected to close on May 28, 2025.Get access to all SEC 8-K filings of the TEVA PHARMACEUTICAL INDUSTRIES LTD